PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 44 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Foundation for the National Institutes of Health
Grant: 1R01DK124095
National Institutes of Health
Grant: CA216746
BLRD VA
Grant: I01 BX002086
NIDDK NIH HHS
Grant: R01 DK124095
NCI NIH HHS
Grant: R21 CA216746
NIGMS NIH HHS
Grant: P30 GM127200
BLRD VA
Grant: I01 BX002761
National Institutes of Health
Grant: 5R21CA216746-02
Mastl, a novel therapeutic target in Colon Cancer
National Institutes of Health
Grant: 5R01DK124095-03
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
Fields of Study
Keywords
Sustainable Development Goals
Additional file 2 of UHMK1-dependent phosphorylation of Cajal body protein coilin alters 5-FU sensitivity in colon cancer cells
Additional file 2 of UHMK1-dependent phosphorylation of Cajal body protein coilin alters 5-FU sensitivity in colon cancer cells
Additional file 3 of UHMK1-dependent phosphorylation of Cajal body protein coilin alters 5-FU sensitivity in colon cancer cells
Additional file 3 of UHMK1-dependent phosphorylation of Cajal body protein coilin alters 5-FU sensitivity in colon cancer cells